Day 3 Parallel Sessions

View Full Program

Friday, April 10, 2026 

Session	Time	Room	Title	Organizers
OpportuNet: Networking Fair	7:30 – 1:15pm	Gallery #1017	Open during duration of symposium	Taylor Krajewski (Duke)
Opening Remarks	8:30 – 9:00am	Auditorium EBC250	Welcome Poster Award Presentations DISS Steering Committee Remarks	Herb Pang (Genentech) Roland Matsouaka / Lisa Wruck (Duke) TBD (Affiliation)
Keynote II	9:00 – 10:00am	Auditorium EBC250	Dr. Udo Sglavo, Vice President, Applied AI and Modeling R&D, SAS Institute Inc.	Fang Chen (SAS Institute Inc.)
Break	10:00 – 10:15am
S4A	10:15 – 11:45am	EBC-7	AI-Driven Analytics: How Modern-Day Statistical Software Charts the Future of Innovation	Fang Chen (SAS)
S4B	10:15 – 11:45am	EBC-8	Conformal Inference for Uncertainty-Aware Machine Learning in Biomedical Research	Ke Zhu (Duke)
S4C	10:15 – 11:45am	EBC-150	Expedite Dose Optimization Using Backfill and Randomization	Ying Yuan (University of Texas)
S4D	10:15 – 11:45am	EBC-9	From Data to Decisions: Bayesian Approaches to Drug Exposure and Dosing	Kevin Gan (ViiV)
Lunch	11:45 – 1:15pm	SAS Cafe (Lower Level) Reserved Seating Area: MarketPlace Sections C, D & E
OpportuNet: Networking Fair	12:30 – 1:15pm	Gallery #1017	Designated time for networking with sponsor representatives. OpportuNet ends at 1:15pm	Taylor Krajewski (Duke)
S5A	1:15 – 3:00pm	EBC-7	AI/Machine Learning Applications and Methods in Clinical Trials	Zoe Hua (Servier)
S5B	1:15 – 3:00pm	EBC-8	Empower Pharmaceutical Developments with Innovative Adaptive Clinical Trials	Kaiyuan Hua (BeOne Medicines)
S5C	1:15 – 3:00pm	EBC-9	Advancing Quantitative Benefit–Risk Assessment in Drug Development: Methodologies, Applications, and Regulatory Perspectives	Zhaoyang Teng (Astellas)
S5D	1:15 – 3:00pm	EBC-150	Go/No-Go Decision Making of Transitioning to Phase 3 Study in Clinical Development	Kentaro Takeda (Astellas)